11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
On July 3, 2019, California Governor Gavin Newsom signed SB 188 into law, creating what is known as ...
Read More >
Seyfarth Synopsis: While employees often will toot their own horn, employers sometimes may have conc...
Read More >
The National Labor Relations Board has reminded employers that they must tolerate a certain degree o...
Read More >
In a recent decision arising out of the sale of Cablevision, the Delaware Court of Chancery issued i...
Read More >
As businesses begin to reopen following the COVID-19 shut down of 2020, it is clear that the "busine...
Read More >
The 2019-2020 U.S. Supreme Court term could have a significant impact on the employment law area, wi...
Read More >